Anti-obesity medication prescriptions by race/ethnicity and use of an interpreter in a pediatric weight management clinic.

"supplemental table 1 ). median household income based upon zip"

"Conflict of interest statement: The authors declared the following potential conflicts of interest with respect to the research, authorship, and/or publication of this article: E.M.B. is a site principal investigator and co-investigator for Novo Nordisk. A.S.K. serves as an unpaid consultant for Novo Nordisk, Vivus, and Eli Lilly, and receives donated drug and placebo from Vivus for a National Institutes of Diabetes and Digestive and Kidney Diseases (NIDDK)-funded clinical trial. C.T.B. is funded by the NIH National Center for Advancing Translational Sciences, grants KL2TR002494 and UL1TR002494. C.K.F. is a site principal investigator and co-investigator for Novo Nordisk. All other authors have no other relevant disclosures. Research reported in this publication was supported by the NIDDK of the National Institutes of Health under Award Number K23DK125668. Additional support was provided by the Minnesota Population Center, which is funded by the Eunice Kennedy Shriver National Institute of Child Health and Human Development (Grant P2 C HD041023), and award number UL1TR002494 from the National Institutes of Health’s National Center for Advancing Translational Sciences. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health."

"Funding: The authors received no financial support for the research, authorship, and/or publication of this article."